Generation of human T lymphocytes from bone marrow CD34+ cells in vitro.

作者: Andrew R. Freedman , Haihong Zhu , James D. Levine , Spyros Kalams , David T. Scadden

DOI: 10.1038/NM0196-46

关键词: CD34LymphopoiesisGeneStem cellIn vitroBone marrowNeutropeniaReceptorImmunologyBiology

摘要: Analysis of the events that regulate development red blood cells or granulocytes has led to therapies altering clinical conditions associated with anemia neutropenia. The therapeutic approaches target lymphopenia, such as AIDS, been thwarted by limited techniques for studying T–lymphocyte development. We describe an in vitro system which human bone marrow CD34+ proliferate, acquire expression lymphoid–specific RAG–2 gene and a broad repertoire rearranged T–cell receptor genes, develop ability produce T cell–specific interleukin–2 achieve range immunophenotypes. also become susceptible infection T–lymphotropic strain immunodeficiency virus–1, HIV–1IIIB. This culture induces lymphopoiesis may permit further analysis regulating T–lineage differentiation. It provides preclinical model screening stem cell directed toward AIDS.

参考文章(30)
M. Oettinger, D. Schatz, C Gorka, D Baltimore, RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science. ,vol. 248, pp. 1517- 1523 ,(1990) , 10.1126/SCIENCE.2360047
Stanley F. Wolf, Derek Sieburth, Joseph Sypek, Interleukin 12: A key modulator of immune function Stem Cells. ,vol. 12, pp. 154- 168 ,(1994) , 10.1002/STEM.5530120203
C. Hannum, J. Culpepper, D. Campbell, T. McClanahan, S. Zurawski, R. Kastelein, J. F. Bazan, S. Hudak, J. Wagner, J. Mattson, J. Luh, G. Duda, N. Martina, D Peterson, S. Menon, A. Shanafelt, M. Muench, G. Kelner, R. Namikawa, D. Rennick, M.-G. Roncarolo, A. Zlotnik, O. Rosnet, P. Dubreuil, D. Birnbaum, F. Lee, Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs Nature. ,vol. 368, pp. 643- 648 ,(1994) , 10.1038/368643A0
T. M. Dexter, T. D. Allen, L. G. Lajtha, Conditions controlling the proliferation of haemopoietic stem cells in vitro. Journal of Cellular Physiology. ,vol. 91, pp. 335- 344 ,(1977) , 10.1002/JCP.1040910303
M Kobayashi, L Fitz, M Ryan, R M Hewick, S C Clark, S Chan, R Loudon, F Sherman, B Perussia, G Trinchieri, Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. Journal of Experimental Medicine. ,vol. 170, pp. 827- 845 ,(1989) , 10.1084/JEM.170.3.827
Stewart D. Lyman, Laura James, Tim Vanden Bos, Peter de Vries, Ken Brasel, Brian Gliniak, L.T. Hollingsworth, Kathleen S. Picha, Hilary J. McKenna, Roxanne R. Splett, Frederick A. Fletcher, Eugene Maraskovsky, Terry Farrah, Diane Foxworthe, Douglas E. Williams, M.Patricia Beckmann, Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells. Cell. ,vol. 75, pp. 1157- 1167 ,(1993) , 10.1016/0092-8674(93)90325-K
S E Jacobsen, O P Veiby, E B Smeland, Cytotoxic lymphocyte maturation factor (interleukin 12) is a synergistic growth factor for hematopoietic stem cells. Journal of Experimental Medicine. ,vol. 178, pp. 413- 418 ,(1993) , 10.1084/JEM.178.2.413
H. K. Lyerly, T. J. Matthews, A. J. Langlois, D. P. Bolognesi, K. J. Weinhold, Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack Proceedings of the National Academy of Sciences of the United States of America. ,vol. 84, pp. 4601- 4605 ,(1987) , 10.1073/PNAS.84.13.4601